Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BSAD-1303
- Development stage
- Unknown
- Lead developer
- Bora Pharmaceuticals
- Modality
- Small Molecules
01
Overview
**BSAD-1303** is an approved over-the-counter small-molecule combination product developed by Bora Pharmaceutical for the treatment of cold and influenza symptoms. Bora's publicly available R&D product material identifies the asset as an approved combination product, but does not disclose its active ingredients, dosage form, route of administration, molecular targets, or detailed mechanism of action.
Beyond the preview
Go deeper on BSAD-1303.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BSAD-1303.